Abstract
The optimization and kinetic of rosmarinic acid extraction from Orthosiphon stamineus were investigated in this study. In the preliminary study, the extractions were carried out to identify the optimal ethanol concentration. Then, the optimal ethanol concentration was used to optimize the extraction variables (solventto- solid loading ratio, temperature and time) by central composite design. The optimum conditions for the rosmarinic acid extraction were at the concentration of ethanol, 70% v/v; solvent-to-solid loading ratio, 9.14; extraction temperature, 56.53°C; and extraction time, 3 hours. Subsequently, this study used six proposed models to describe the kinetic of the rosmarinic acid extraction. Two-site kinetic model gave the best fit for the experimental data with the highest coefficient of determination, R2 (0.976) and the smallest values of root mean square error (RMSE) (1.522). The goodness of fit is due to the presence of the rate constants of both fast and slow released fractions in the model. Hence, two-site kinetic model is the most appropriate model to describe the rosmarinic acid extraction from O. stamineus in a reflux extraction system.
Keywords: Central Composite design, extraction, kinetic modeling, Orthosiphon stamineus, response surface methodology, rosmarinic acid.
Current Bioactive Compounds
Title:Optimization and Kinetic Modeling of Rosmarinic Acid Extraction from Orthosiphon stamineus
Volume: 10 Issue: 4
Author(s): Cher H. Lau, Lee S. Chua, Chew T. Lee and Ramlan Aziz
Affiliation:
Keywords: Central Composite design, extraction, kinetic modeling, Orthosiphon stamineus, response surface methodology, rosmarinic acid.
Abstract: The optimization and kinetic of rosmarinic acid extraction from Orthosiphon stamineus were investigated in this study. In the preliminary study, the extractions were carried out to identify the optimal ethanol concentration. Then, the optimal ethanol concentration was used to optimize the extraction variables (solventto- solid loading ratio, temperature and time) by central composite design. The optimum conditions for the rosmarinic acid extraction were at the concentration of ethanol, 70% v/v; solvent-to-solid loading ratio, 9.14; extraction temperature, 56.53°C; and extraction time, 3 hours. Subsequently, this study used six proposed models to describe the kinetic of the rosmarinic acid extraction. Two-site kinetic model gave the best fit for the experimental data with the highest coefficient of determination, R2 (0.976) and the smallest values of root mean square error (RMSE) (1.522). The goodness of fit is due to the presence of the rate constants of both fast and slow released fractions in the model. Hence, two-site kinetic model is the most appropriate model to describe the rosmarinic acid extraction from O. stamineus in a reflux extraction system.
Export Options
About this article
Cite this article as:
H. Lau Cher, S. Chua Lee, T. Lee Chew and Aziz Ramlan, Optimization and Kinetic Modeling of Rosmarinic Acid Extraction from Orthosiphon stamineus, Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/157340721004150206151452
DOI https://dx.doi.org/10.2174/157340721004150206151452 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Targeting of P-Selectin in Atherosclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Deaza Analogs of Folic Acid as Antitumor Agents
Current Pharmaceutical Design A Systematic Review and Meta-analysis of Clinical Studies on Ankylosing Spondylitis and Neutrophil to Lymphocyte Ratio
Current Rheumatology Reviews Cognitive - Behavioral Therapy in Central Sensitivity Syndromes
Current Rheumatology Reviews Proteomic Analysis of Cerebrospinal Fluid: A Search for Biomarkers of Neuropsychiatric Systemic Lupus Erythematosus
Current Proteomics YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease
Current Neuropharmacology Hypovitaminosis D in Patients with Ankylosing Spondylitis: Frequency and Consequences
Current Rheumatology Reviews Renal Biopsy Research with Implications for Therapy of Glomerulonephritis
Current Drug Therapy A Review of Current Knowledge of the Complement System and the Therapeutic Opportunities in Inflammatory Arthritis
Current Medicinal Chemistry Contribution of Dietary Factors to Peroxisome Proliferator-Activated Receptor-Mediated Inflammatory Signaling in Arthritic Diseases
Current Rheumatology Reviews Cholinergic Targets in Lung Cancer
Current Pharmaceutical Design Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review
Current Medicinal Chemistry NF-κB in Anti-Inflammatory Activity of Probiotics: An Update
Current Immunology Reviews (Discontinued) Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Current Pharmaceutical Design The Potential use of Dendritic Cell-based Immunotherapy for Treatment of Pancreatic Cancer
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Immunogenetic Mechanisms Leading to Thyroid Autoimmunity: Recent Advances in Identifying Susceptibility Genes and Regions
Current Genomics Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease
Recent Patents on Inflammation & Allergy Drug Discovery In Vitro and In Vivo Experimental Model-based Approaches for Investigating Anti-inflammatory Properties of Coumarins
Current Medicinal Chemistry Viral Anti-Inflammatory Reagents: The Potential for Treatment of Arthritic and Vasculitic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets